Strs Ohio Has $70.46 Million Holdings in CVS Health Corporation $CVS

Strs Ohio cut its holdings in CVS Health Corporation (NYSE:CVS) by 14.9% during the 4th quarter, HoldingsChannel reports. The fund owned 887,820 shares of the pharmacy operator’s stock after selling 155,430 shares during the quarter. Strs Ohio’s holdings in CVS Health were worth $70,457,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Sei Investments Co. grew its stake in CVS Health by 17.4% during the second quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator’s stock worth $62,474,000 after buying an additional 134,535 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in CVS Health by 1.2% during the second quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator’s stock worth $77,353,000 after buying an additional 13,329 shares in the last quarter. Treasurer of the State of North Carolina grew its stake in CVS Health by 1.3% during the second quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator’s stock worth $40,358,000 after buying an additional 7,588 shares in the last quarter. HUB Investment Partners LLC grew its stake in CVS Health by 25.0% during the second quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator’s stock worth $1,039,000 after buying an additional 3,011 shares in the last quarter. Finally, Alliancebernstein L.P. grew its stake in CVS Health by 8.0% during the second quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator’s stock worth $111,017,000 after buying an additional 119,439 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Regulatory tailwinds for Aetna and clearer PBM policy raised upside visibility for CVS’s Health Services and PBM businesses, boosting investor optimism about Medicare Advantage payments and reduced insulin?pricing uncertainty. Regulatory Tailwinds Article
• Positive Sentiment: Operational efficiency gains from automation: WSJ reports on CVS’s new highly automated distribution center using robots to move millions of items with far fewer staff — a potential long?term margin lever. Robotics/Operations Article
• Positive Sentiment: Competitive positioning: coverage notes CVS is pushing health?services expansion while Walgreens pulls back, which could support share gains in higher?margin care services. Competitive Positioning Article
• Neutral Sentiment: Earnings preview / analyst focus: Wall Street is parsing Q1 metrics (revenue, pharmacy trends and Health Services growth). Investors are waiting for the company’s March?quarter results and management color before re?rating shares. Earnings Countdown Article
• Negative Sentiment: Near?term margin risk: earnings previews caution that benefits segment pressures and elevated costs could weigh on Q1 results, a key reason investors are cautious ahead of the print. Earnings Preview Article
• Negative Sentiment: Market dynamics and valuation: after a strong run-up, the stock’s rich near?term multiples and lighter intraday volume can amplify down?moves as investors lock in gains while awaiting Q1 clarity (contributing to today’s pullback).

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Argus reduced their price objective on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Bank of America reduced their price target on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research note on Tuesday, January 27th. Leerink Partners restated an “outperform” rating and issued a $98.00 price target on shares of CVS Health in a research note on Thursday, March 5th. The Goldman Sachs Group raised their price target on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research note on Thursday, February 12th. Finally, TD Cowen restated a “buy” rating on shares of CVS Health in a research note on Friday, March 13th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $95.05.

CVS Health Trading Down 1.4%

CVS opened at $82.12 on Friday. The company’s 50 day moving average is $76.32 and its 200-day moving average is $77.97. CVS Health Corporation has a 1-year low of $58.35 and a 1-year high of $85.15. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The company has a market cap of $105.24 billion, a P/E ratio of 59.51, a PEG ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm’s quarterly revenue was up 8.2% compared to the same quarter last year. During the same period last year, the company posted $1.19 EPS. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities research analysts predict that CVS Health Corporation will post 7.14 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, May 4th. Investors of record on Thursday, April 23rd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.2%. The ex-dividend date is Thursday, April 23rd. CVS Health’s dividend payout ratio (DPR) is 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.